Daphne Hessels

4.5k citations

48 papers · 3.5k indexed · 1 hit paper · h-index 23

Pulmonary and Respiratory Medicine top 0.5%
Molecular Biology top 5%
Cancer Research top 1%
Surgery top 10%
Rheumatology top 5%

Co-authors: Jack A. Schalken Gerald W. Verhaegh J. Alfred Witjes Lambertus A. Kiemeney Inge M. van Oort Erik B. Cornel Frank Smit Sander A. Jannink
Topics: Prostate Cancer Treatment and Research (33 papers)Prostate Cancer Diagnosis and Treatment (26 papers)Molecular Biology Techniques and Applications (13 papers)
Cited by: Cancer Research Pulmonary and Respiratory Medicine Molecular Biology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
Partner nations: Netherlands Belgium United States

In The Last Decade

Daphne Hessels

47 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

2003 532 citations Daphne Hessels, Inge M. van Oort et al. European Urology profile →

Peers

Countries citing papers authored by Daphne Hessels

Since Specialization

Citations

This map shows the geographic impact of Daphne Hessels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daphne Hessels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daphne Hessels more than expected).

Fields of papers citing papers by Daphne Hessels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daphne Hessels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daphne Hessels. The network helps show where Daphne Hessels may publish in the future.

Co-authorship network of co-authors of Daphne Hessels

This figure shows the co-authorship network connecting the top 25 collaborators of Daphne Hessels. A scholar is included among the top collaborators of Daphne Hessels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daphne Hessels. Daphne Hessels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	COST-EFFECTIVENESS OF SELECTMDX FOR PROSTATE CANCER IN FOUR EUROPEAN COUNTRIES: A MODELLING STUDY 2018 ·Ghent University Academic Bibliography (Ghent University) ·Daphne Hessels,Tim M. Govers,Wim Van Criekinge,Virginie Vlaeminck‐Guillem,Bernd J. Schmitz‐Dräger,Christian G. Stief,(unknown)	1
2	Prostate Cancer Antigen 3: Diagnostic Outcomes in Men Presenting With Urinary Prostate Cancer Antigen 3 Scores ≥100 2014 ·Urology ·Fritz H. Schröder,Lionne D. F. Venderbos,Roderick C.N. van den Bergh,Daphne Hessels,Geert J.L.H. van Leenders,Pim J. van Leeuwen,Tineke Wolters,Jelle O. Barentsz,Monique J. Roobol	13
3	Urinary biomarkers for prostate cancer: a review 2013 ·Asian Journal of Andrology ·Daphne Hessels,Jack A. Schalken	64
4	Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis 2012 ·The Prostate ·G. Robert,Sander A. Jannink,Frank Smit,Tilly Aalders,Daphne Hessels,R.G.H.M. Cremers,Peter F.A. Mulders,Jack A. Schalken	42
5	Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer 2012 ·European Urology ·G.H.J.M. Leyten,Daphne Hessels,Sander A. Jannink,Frank Smit,Hans de Jong,Erik B. Cornel,Theo M. de Reijke,H. Vergunst,Paul J.M. Kil,Ben C. Knipscheer,Inge M. van Oort,Peter F.A. Mulders,Christina A. Hulsbergen‐van de Kaa,Jack A. Schalken	268
6	Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia 2011 ·The Prostate ·G. Robert,Frank Smit,Daphne Hessels,Sander A. Jannink,Herbert F.M. Karthaus,Tilly Aalders,(unknown),Alexandre de la Taille,Peter F.A. Mulders,Jack A. Schalken	20
7	Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test 2010 ·European Urology ·Monique J. Roobol,Fritz H. Schröder,Pim van Leeuwen,Tineke Wolters,Roderick C.N. van den Bergh,Geert J.L.H. van Leenders,Daphne Hessels	134
8	Performance of Prostate Cancer Antigen 3 (PCA3) and Prostate-Specific Antigen in Prescreened Men: Reproducibility and Detection Characteristics for Prostate Cancer Patients with High PCA3 Scores (≥100) 2010 ·European Urology ·Monique J. Roobol,Fritz H. Schröder,(unknown),Daphne Hessels,Roderick C.N. van den Bergh,Tineke Wolters,Pim J. van Leeuwen	41
9	Predictive value of PCA3 in urinary sediments in determining clinico‐pathological characteristics of prostate cancer 2009 ·The Prostate ·Daphne Hessels,Martijn P.M.Q. van Gils,Onno van Hooij,Sander A. Jannink,J. Alfred Witjes,Gerald W. Verhaegh,Jack A. Schalken	128
10	Preliminary evaluation of the effect of dutasteride on PCA3 in post‐DRE urine sediments: A randomized, open‐label, parallel‐group pilot study 2009 ·The Prostate ·Martijn P.M.Q. van Gils,Daphne Hessels,W. P. Peelen,H. Vergunst,Peter F.A. Mulders,Jack A. Schalken	17
11	Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results 2008 ·The Prostate ·Martijn P.M.Q. van Gils,Daphne Hessels,Christina A. Hulsbergen‐van de Kaa,J. Alfred Witjes,Cornelius F.J. Jansen,Peter F.A. Mulders,Harry G. Rittenhouse,Jack A. Schalken	61
12	Molecular PCA3 diagnostics on prostatic fluid 2007 ·The Prostate ·Martijn P.M.Q. van Gils,Erik B. Cornel,Daphne Hessels,W. P. Peelen,J. Alfred Witjes,Peter F.A. Mulders,Harry G. Rittenhouse,Jack A. Schalken	43
13	Polycomb-Group Oncogenes EZH2, BMI1, and RING1 Are Overexpressed in Prostate Cancer With Adverse Pathologic and Clinical Features 2006 ·European Urology ·Geert J.L.H. van Leenders,Danny F. Dukers,Daphne Hessels,(unknown),(unknown),J.A. Witjes,Arie P. Otte,Chris J.L.M. Meijer,Frank M. Raaphorst	149
14	Applicability of biomarkers in the early diagnosis of prostate cancer 2004 ·Expert Review of Molecular Diagnostics ·Daphne Hessels,Gerald W. Verhaegh,Jack A. Schalken,J.A. Witjes	43
15	DD3, a very sensitive and specific merker to detect prostate tumors. Reply to: Gandino O, Santulli M, Cardillo MR, Stigliano A, Toscano V. Correspondence re: J.B. de Kok et al. 2003 ·Cancer Research ·Gerald W. Verhaegh,Jacques B de Kok,Daphne Hessels,Frank Smit,Jack A. Schalken	2
16	New targets for therapy in prostate cancer: differential display code 3 (DD3PCA3), a highly prostate cancer–specific gene 2003 ·Urology ·Jack A. Schalken,Daphne Hessels,Gerald W. Verhaegh	102
17	Widely used prostate carcinoma cell lines share common origins 2001 ·The Prostate ·Adrie van Bokhoven,Marileila Varella‐Garcia,Christopher Korch,Daphne Hessels,Gary J. Miller	68
18	p53‐Independent Apoptosis Induced by Menadione in the Human Colon Carcinoma Cell Line Caco‐2 2000 ·Annals of the New York Academy of Sciences ·Jacek Karczewski,Jacqueline A. M. Vet,Daphne Hessels,J. Noordhoek	7
19	Comparative Analysis ofp53Mutations in Bladder Washings and Histologic Specimens 1998 ·American Journal of Clinical Pathology ·Jacqueline A. M. Vet,Daphne Hessels,Salvatore A. E. Marras,(unknown),H.G. Van Der Poel,Rob Michalides,F.M.J. Debruyne,(unknown)	5
20	MULTIFOCAL TRANSITIONAL CELL CANCER AND p53 MUTATION ANALYSIS 1998 ·The Journal of Urology ·H.G. Van Der Poel,Daphne Hessels,Geert J.L.H. van Leenders,Marion J.G. Bussemakers,Jack A. Schalken,J. Alfred Witjes,F.M.J. Debruyne	1

About Daphne Hessels

Daphne Hessels is a scholar working on Pulmonary and Respiratory Medicine, Urology and Cancer Research, having authored 48 papers that have together received 3.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (33 papers), Prostate Cancer Diagnosis and Treatment (26 papers) and Molecular Biology Techniques and Applications (13 papers). The work is most often cited by research in Cancer Research (1.5k citations), Pulmonary and Respiratory Medicine (2.3k citations) and Molecular Biology (1.7k citations). Daphne Hessels has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Jack A. Schalken, Gerald W. Verhaegh, J. Alfred Witjes, Lambertus A. Kiemeney, Inge M. van Oort, Erik B. Cornel, Frank Smit, Sander A. Jannink, Herbert F.M. Karthaus and Tilly Aalders. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact